J 2017

Response by Motovska et al to Letter Regarding Article, "Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study"

MOTOVSKA, Z., Ota HLINOMAZ and Petr KALA

Basic information

Original name

Response by Motovska et al to Letter Regarding Article, "Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study"

Authors

MOTOVSKA, Z. (203 Czech Republic), Ota HLINOMAZ (203 Czech Republic, belonging to the institution) and Petr KALA (203 Czech Republic, guarantor, belonging to the institution)

Edition

Circulation, Philadelphia, Lippincott Williams Wilkins, 2017, 0009-7322

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30201 Cardiac and Cardiovascular systems

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 18.881

RIV identification code

RIV/00216224:14110/17:00098711

Organization unit

Faculty of Medicine

DOI

UT WoS

000398851900003

Keywords in English

Prasugrel Versus Ticagrelor

Tags

Tags

International impact, Reviewed
Změněno: 20/3/2018 17:49, Soňa Böhmová

Abstract

V originále

Letter Response by Motovska et al to Letter Regarding Article, "Prasugrel Versus Ticagrelor in Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Multicenter Randomized PRAGUE-18 Study".